A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma

RECOMMENDED

Pleural Diseases

Investigating unilateral pleural effusions: the role of cytology

Eur Respir J.

Arnold DT, De Fonseka D, Perry S, Morley , Harvey JE, Medford A, Brett M, Maskell NA

doi: 10.1183/13993003.

Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion

Interact Cardiovasc Thorac Surg.

Liu C, Huang L, Zhang X, Yang J

doi: 10.1093/icvts/ivx327.

RECOMMENDED

Lung Cancer

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Lancet Respir Med.

Scagliotti GV, Gaafar R, Nowak AK, Nakano T, van Meerbeeck J, Popat S, Vogelzang NJ, Grosso F, Aboelhassan R, Jakopovic M, Ceresoli GL, Taylor P, Orlandi F, Fennell DA, Novello S, Scherpereel A, Kuribayashi K, Cedres S, Sørensen JB, Pavlakis N, Reck M, Velema D, von Wangenheim U, Kim M, Barrueco J, Tsao AS

doi: 10.1016/S2213-2600(19)30139-0.

Pleural Diseases

Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters

Curr Opin Pulm Med.

Vakil E, Jimenez CA, Faiz SA

doi: 10.1097/MCP.

ERS/EACTS statement on the management of malignant pleural effusions

Eur Respir J.

Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA

doi: 10.1183/

Pleural Diseases

Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial

Lancet Respir Med.

Muruganandan S, Azzopardi M, Fitzgerald DB, Shrestha R, Kwan BCH, Lam DCL, De Chaneet CC, Rashid Ali MRS, Yap E, Tobin CL, Garske LA, Nguyen PT, Stanley C, Popowicz ND, Kosky C, Thomas R, Read CA, Budgeon CA, Feller-Kopman D, Maskell NA, Murray K, Lee YCG

doi: 10.1016/S2213-2600

Malignant Pleural Mesothelioma: State of the art and advanced cell therapy

Eur J Med Chem.

Facchetti G, Petrella F, Spaggiari L, Rimoldi I

doi: 10.1016/

RECOMMENDED

Pleural Diseases

In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea

PLoS One.

Garske LA, Kunarajah K, Zimmerman PV, Adams L, Stewart IB

doi: 10.1371/journal.pone.

COMMENTED

CoughPleural Diseases

Pleural manometry in patients with pleural diseases - the usefulness in clinical practice

Respir Med.

Grabczak EM, Krenke R, Zielinska-Krawczyk M, Light RW

doi: 10.1016/j.rmed.2018.01.014.

Related content

Investigating unilateral pleural effusions: the role of cytology

Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters

ERS/EACTS statement on the management of malignant pleural effusions

Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial

Malignant Pleural Mesothelioma: State of the art and advanced cell therapy

In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea

Pleural manometry in patients with pleural diseases - the usefulness in clinical practice